Artikel ; Online: Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.
Cardiovascular journal of Africa
2016 Band 27, Heft 3, Seite(n) 128–133
Abstract: Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when ... ...
Abstract | Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when severe atherosclerosis is the underlying cause. In this study, we retrospectively analysed renal outcomes after iloprost infusion therapy in 86 patients. Methods: Eighty-six patients with PAD who received iloprost infusion therapy were retrospectively analysed. Clinical and biochemical parameters were recorded before (initial, Cr1), during (third day, Cr2), and after (14th day following the termination of infusion therapy, Cr3) treatment. Acute kidney injury (AKI) was defined according to KDIGO guidelines as a ≥ 0.3 mg/dl (26.52 µmol/l) increase in creatinine levels from baseline within 48 hours. Results: Cr2 (1.46 ± 0.1 mg/dl) (129.06 ± 8.84 µmol/l) and Cr3 (1.53 ± 0.12 mg/dl) (135.25 ± 10.61 µmol/l) creatinine levels were significantly higher compared to the initial value (1.15 ± 0.6 mg/dl) (101.66 ± 53.04 µmol/l). AKI was observed in 36 patients (41.86%) on the third day of iloprost infusion. Logistic regression analysis revealed smoking and not using acetylsalicylic acid as primary predictors (p = 0.02 and p = 0.008, respectively) of AKI during iloprost treatment. On the third infusion day, patients' urinary output significantly increased (1813.30 ± 1123.46 vs 1545.17 ± 873.00 cm Conclusion: While iloprost treatment is effective in patients with PAD who are not suitable for surgery, severe systemic vasodilatation can cause renal ischaemia, resulting in nonoliguric AKI. Smoking, no acetylsalicylic acid use, and lower diastolic blood pressure are the clinical risk factors for AKI during iloprost treatment. |
|||||
---|---|---|---|---|---|---|
Mesh-Begriff(e) | Acute Kidney Injury/blood ; Acute Kidney Injury/chemically induced ; Acute Kidney Injury/diagnosis ; Acute Kidney Injury/mortality ; Aged ; Aged, 80 and over ; Arterial Pressure ; Aspirin/therapeutic use ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/drug therapy ; Atherosclerosis/mortality ; Atherosclerosis/physiopathology ; Biomarkers/blood ; Chi-Square Distribution ; Creatinine/blood ; Female ; Humans ; Iloprost/administration & dosage ; Iloprost/adverse effects ; Infusions, Intravenous ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Protective Factors ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Smoking/adverse effects ; Time Factors ; Treatment Outcome ; Up-Regulation ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects | |||||
Chemische Substanzen | Biomarkers ; Platelet Aggregation Inhibitors ; Vasodilator Agents ; Creatinine (AYI8EX34EU) ; Iloprost (JED5K35YGL) ; Aspirin (R16CO5Y76E) | |||||
Sprache | Englisch | |||||
Erscheinungsdatum | 2016-05 | |||||
Erscheinungsland | South Africa | |||||
Dokumenttyp | Journal Article | |||||
ZDB-ID | 2383233-2 | |||||
ISSN | 1680-0745 ; 1996-3467 ; 1015-9657 ; 1995-1892 | |||||
ISSN (online) | 1680-0745 ; 1996-3467 | |||||
ISSN | 1015-9657 ; 1995-1892 | |||||
DOI | 10.5830/CVJA-2015-051 | |||||
Signatur |
|
|||||
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 4813: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.